A multicenter, double-blind, placebo-controlled randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo in patients (pts) with malignant mesothelioma (MM) Meeting Abstract
| Authors: | Kindler, H. L.; Karrison, T.; Lu, C.; Gandara, D. R.; Stevenson, J.; Krug, L.; Janne, P.; Guterz, T. L.; Stadler, W. M.; Vokes, E. E. |
| Abstract Title: | A multicenter, double-blind, placebo-controlled randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo in patients (pts) with malignant mesothelioma (MM) |
| Meeting Title: | 41st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 23 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2005 May 13-17 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2005-06-01 |
| Start Page: | 625S |
| Language: | English |
| ACCESSION: | WOS:000230326604137 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2005.23.16_suppl.7019 |
| Notes: | --- - Meeting Abstract: 7019 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work